Insider · CIK 0001383292

Rowland Charles A Jr

Reports to the SEC for 10 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001383292

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,200 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,920 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,500 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,246 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co.U Disposition from Tender	Director	UDisposition from Tender	−53.5K sh	—	—	0
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,000 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	—	—	0
2026-01-02	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20.4K sh	—	—	20,400
2026-01-02	VKTXViking Therapeutics, Inc.A Award	Director	AAward	+3,150 sh	—	—	33,150
2025-10-27	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−16K sh	—	—	0
2025-10-27	VKTXViking Therapeutics, Inc.A Award	Director	AAward	+16K sh	$4.48	+$71.7K	46,000
2025-10-27	VKTXViking Therapeutics, Inc.S Sale	Director	SSale	−60K sh	$35.57	−$2.13M	30,000
2025-10-27	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−22K sh	—	—	0
2025-10-27	VKTXViking Therapeutics, Inc.A Award	Director	AAward	+22K sh	$4.88	+$107K	90,000
2025-10-27	VKTXViking Therapeutics, Inc.A Award	Director	AAward	+22K sh	$5.80	+$128K	68,000
2025-10-27	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−22K sh	—	—	0
2025-06-04	GBIOGeneration Bio Co. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2025-01-02	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.8K sh	—	—	18,800
2024-06-06	GBIOGeneration Bio Co. · Stock Option (right to buy)A Award	Director	AAward	+60K sh	—	—	60,000
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−105K sh	—	—	0
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−46K sh	—	—	0
2024-01-24	Orchard Therapeutics plcD Disposition to Issuer	Director	DDisposition to Issuer	−12.3K sh	—	—	0
2024-01-02	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+32K sh	—	—	32,000
2023-12-04	GBIOGeneration Bio Co.P Purchase	Director	PPurchase	+150K sh	$1.50	+$225K	534,757
2023-12-01	GBIOGeneration Bio Co.P Purchase	Director	PPurchase	+193K sh	$1.31	+$253K	384,757
2023-06-14	Orchard Therapeutics plcStock Option (Right to Buy)A Award	Director	AAward	+105K sh	—	—	105,000
2023-06-08	GBIOGeneration Bio Co. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2023-05-16	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−40K sh	—	—	0
2023-05-16	VKTXViking Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+40K sh	$1.08	+$43.2K	70,000
2023-05-16	VKTXViking Therapeutics, Inc.S Sale	Director	SSale	−40K sh	$25.00	−$1M	30,000
2023-01-03	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,000
2022-09-19	GBIOGeneration Bio Co.P Purchase	Director	PPurchase	+15.8K sh	$5.26	+$82.8K	191,797
2022-09-16	GBIOGeneration Bio Co.P Purchase	Director	PPurchase	+33.5K sh	$5.48	+$183K	176,047
2022-09-15	GBIOGeneration Bio Co.P Purchase	Director	PPurchase	+17.1K sh	$5.41	+$92.8K	142,566
2022-09-14	GBIOGeneration Bio Co.P Purchase	Director	PPurchase	+5,600 sh	$5.29	+$29.7K	125,419
2022-09-13	GBIOGeneration Bio Co.P Purchase	Director	PPurchase	+18.8K sh	$5.20	+$97.8K	119,819
2022-08-01	Nabriva Therapeutics plcS Sale	Director	SSale	−8,496 sh	$0.17	−$1,486.8	15,277
2022-06-09	GBIOGeneration Bio Co. · Stock Option (right to buy)A Award	Director	AAward	+19.2K sh	—	—	19,200
2022-06-07	Orchard Therapeutics plcStock Option (Right to Buy)A Award	Director	AAward	+46K sh	—	—	46,000
2022-01-03	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,000
2021-08-02	Nabriva Therapeutics plcS Sale	Director	SSale	−777 sh	$1.20	−$932.4	23,773
2021-07-28	Nabriva Therapeutics plcA Award	Director	AAward	+17.5K sh	—	—	24,550
2021-07-28	Nabriva Therapeutics plcShare OptionsA Award	Director	AAward	+35K sh	—	—	35,000
2021-06-16	Orchard Therapeutics plcStock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2021-06-09	GBIOGeneration Bio Co. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-06-02	Blueprint Medicines CorpA Award	Director	AAward	+2,250 sh	—	—	5,812
2021-06-02	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Director	AAward	+4,500 sh	—	—	4,500
2021-01-11	GBIOGeneration Bio Co.P Purchase	Director	PPurchase	+20.4K sh	$24.50	+$500K	101,035
2021-01-04	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,000

Recent filings

Accepted (ET)
Feb 94
Rowland Charles A Jr0001104659-26-012196
SEC(opens sec.gov)
Jan 54
Rowland Charles A Jr0001193125-26-003110
SEC(opens sec.gov)
Oct 284
Rowland Charles A Jr0001193125-25-254300
SEC(opens sec.gov)
Jun 64
Rowland Charles A Jr0001415889-25-015960
SEC(opens sec.gov)
Jan 64
Rowland Charles A Jr0000950170-25-002482
SEC(opens sec.gov)
Jun 104
Rowland Charles A Jr0001415889-24-016185
SEC(opens sec.gov)

Companies

Address

C/O GENERATION BIO CO. 301 BINNEY ST, SUITE 401

CAMBRIDGE, MA, 02142